Immediate Impact

61 standout
Sub-graph 1 of 23

Citing Papers

Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis
2025 Standout
2 intermediate papers

Works of Fabrizio C. Lucchini being referenced

Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
2019
Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance
2015

Author Peers

Author Last Decade Papers Cites
Fabrizio C. Lucchini 162 131 73 8 286
Emilia Amengual-Cladera 123 200 115 15 333
Ida Alexandersson 139 204 93 9 303
Shima Taherkhani 101 128 49 6 322
Yongjun Bu 109 96 61 12 309
Raja Gopal Reddy Mooli 146 120 78 12 291
Kento Hara 136 116 105 13 320
Minqian Shen 108 80 83 11 329
Martina Häckl 77 71 73 11 246
Brydie R. Huckestein 77 99 135 13 302
Satoko Senda 124 154 59 8 310

All Works

Loading papers...

Rankless by CCL
2026